Siderophores as "Trojan Horses": Tackling multidrug resistance?

Frontiers in Microbiology

Volumn 5, Issue JUN, 2014, Pages

  De Carvalho, Carla C C R ^a   Fernandes, Pedro ^a,b  

^a INSTITUTO SUPERIOR TÉCNICO   (Portugal)

^b UNIVERSIDADE LUSÓFONA DE HUMANIDADES E TECNOLOGIAS   (Portugal)

Author keywords

Anti bacterial acitivity; Drug delivery; Iron transport; Multidrug resistance; Siderophore conjugates

Indexed keywords

EID: 84905177070     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2014.00290     Document Type: Note

References (20)

1. Anderson, C. P., Shen, M., Eisenstein, R. S., and Leibold, E. A. (2012). Mammalian iron metabolism and its control by iron regulatory protein. Biochim. Biophys. Acta 1823, 1468-1483. doi: 10.1016/j.bbamcr.2012.05.010
2. Braun, V., Günthner, K., Hantke, K., and Zimmermann, L. (1983). Intracellular activation of albomycin in Escherichia coli and Salmonella typhimurium. J. Bacteriol. 156, 308-315.
3. Butler, M. S., Blaskovich, M. A., and Cooper, M. A. (2013). Antibiotics in the clinical pipeline in 2013. J. Antibiot. (Tokyo) 66, 571-591. doi: 10.1038/ja.2013.86
4. Clifton, M. C., Corrent, C., and Strong, R. K. (2009). Siderocalins: siderophore-binding proteins of the innate immune system. Biometals 22, 557-564. doi: 10.1007/s10534-009-9207-6
5. Fukushima, T., Allred, B. E., Sia, A. K., Nichiporuk, R., Andersen, U. N., and Raymond, K. N. (2013). Gram-positive siderophore-shuttle with iron-exchange from Fe-siderophore to apo-siderophore by Bacillus cereus YxeB. Proc. Natl. Acad. Sci. U.S.A. 110, 13821-13826. doi: 10.1073/pnas.1304235110
6. Higgins, P. G., Stefanik, D., Page, M. G. P., Hackel, M., and Seifert, H. (2012). In vitro activity of the siderophore monosulfactam BAL30072 against meropenem-non-susceptible Acinetobacter baumannii. J. Antimicrob. Chemother. 67, 1167-1169. doi: 10.1093/jac/dks009
7. Hofer, B., Dantier, C., Gebhardt, K., Desarbre, E., Schmitt-Hoffmann, A., and Page, M. G. (2013). Combined effects of the siderophore monosulfactam BAL30072 and carbapenems on multidrug-resistant Gram-negative bacilli. J. Antimicrob. Chemother. 68, 1120-1129. doi: 10.1093/jac/dks527
8. Juárez-Hernández, R. E., Franzblau, S. G., and Miller, M. J. (2012). Syntheses of mycobactin analogs as potent and selective inhibitors of Mycobacterium tuberculosis. Org. Biomol. Chem. 10, 7584-7593. doi: 10.1039/c2ob26077h
9. Miller, M. J., Walz, A. J., Zhu, H., Wu, C., Moraski, G., Möllmann, U., et al. (2011). Design, synthesis, and study of a mycobactin-artemisinin conjugate that has selective and potent activity against tuberculosis and malaria. J. Am. Chem. Soc. 133, 2076-2079. doi: 10.1021/ja109665t
10. Mima, T., Kvitko, B. H., Rholl, D. A., Page, M. G., Desarbre, E., and Schweizer, H. P. (2011). In vitro activity of BAL30072 against Burkholderia pseudomallei. Int. J. Antimicrob. Agents 38, 157-159. doi: 10.1016/j.ijantimicag.2011.03.019
11. Mislin, G. L. A., and Schalk, I. J. (2014). Siderophore-dependent iron uptake systems as gates for antibiotic Trojan horse strategies against Pseudomonas aeruginosa. Metallomics 6, 408-420. doi: 10.1039/c3mt00359k
12. Möllmann, U., Heinisch, L., Bauernfeind, A., Köhler, T., and Ankel-Fuchs, D. (2009). Siderophores as drug delivery agents: application of the "Trojan Horse" strategy. Biometals 22, 615-624. doi: 10.1007/s10534-009-9219-2
13. Mushtaq, S., Warner, M., and Livermore, D. (2010). Activity of the siderophore monobactam BAL30072 against multiresistant non-fermenters. J. Antimicrob. Chemother. 65, 266-270. doi: 10.1093/jac/dkp425
14. Page, M. G., Dantier, C., and Desarbre, E. (2010). In vitro properties of BAL30072, a novel siderophore sulfactam with activity against multiresistant gram-negative bacilli Antimicrob. Agents Chemother. 54, 2291-2302. doi: 10.1128/AAC.01525-09
15. Page, M. G. P. (2013). Siderophore conjugates. Ann. N.Y. Acad. Sci. 1277, 115-126. doi: 10.1111/nyas.12024
16. Russo, T. A., Page, M. G., Beanan, J. M., Olson, R., Hujer, A. M., Hujer, K. M., et al. (2011). In vivo and in vitro activity of the siderophore monosulfactam BAL30072 against Acinetobacter baumannii. J. Antimicrob. Chemother. 66, 867-873. doi: 10.1093/jac/dkr013
17. Skaar, E. P. (2010). The battle for iron between bacterial pathogens and their vertebrate hosts. PLoS Pathog. 6:e1000949. doi: 10.1371/journal.ppat.1000949
18. Starr, J., Brown, M. F., Aschenbrenner, L., Caspers, N., Che, Y., Gerstenberger, B. S., et al. (2014). Siderophore receptor-mediated uptake of lactivicin analogues in gram-negative bacteria. J. Med. Chem. 57, 3845-3855. doi: 10.1021/jm500219c
19. Wencewicz, T. A., Long, T. E., Moöllmann, U., and Miller, M. J. (2013). Trihydroxamate siderophore-fluoroquinolone conjugates are selective sideromycin antibiotics that target Staphylococcus aureus. Bioconjug. Chem. 24, 473-486. doi: 10.1021/bc300610f
20. Wencewicz, T. A., and Miller, M. J. (2013). Biscatecholate-Monohydroxamate Mixed Ligand Siderophore-Carbacephalosporin Conjugates are Selective Sideromycin Antibiotics that Target Acinetobacter baumannii. J. Med. Chem. 56, 4044-4052. doi: 10.1021/jm400265k